摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5S,1'S)-5-{1',2'-dihydroxy-1',2'-O-isopropylidene-ethyl}-tetrahydrofuran-2-one | 128856-61-1

中文名称
——
中文别名
——
英文名称
(5S,1'S)-5-{1',2'-dihydroxy-1',2'-O-isopropylidene-ethyl}-tetrahydrofuran-2-one
英文别名
(4S,5R)-4-<5,6-O-(1-methylethylidene)>-γ-hexanolactone;(+)-(4'R,5S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4,5-dihydro-2(3H)-furanone;(4'R,5S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4,5-dihydro-2(3H)-furanone;(4'R,5S)-5-(2',2'-Dimethyl-1',3'-dioxolan-4'-yl)tetrahydrofuran-2-one;(4S,5R)-4,5,6-trihydroxy-5,6-O-isopropylidene-hexanoic acid-1,4-lactone;(5S)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]oxolan-2-one
(5S,1'S)-5-{1',2'-dihydroxy-1',2'-O-isopropylidene-ethyl}-tetrahydrofuran-2-one化学式
CAS
128856-61-1
化学式
C9H14O4
mdl
——
分子量
186.208
InChiKey
VXUSVYYHOQSFDJ-NKWVEPMBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The First Total Synthesis of Annonacin, the Most Typical Monotetrahydrofuran Annonaceous Acetogenins
    作者:Tai-Shan Hu、Yu-Lin Wu、Yikang Wu
    DOI:10.1021/ol005504g
    日期:2000.4.1
    The first total synthesis of annonacin (1) was achieved by a highly convergent synthetic strategy. All the stereogenic centers were derived from three natural hydroxy acids respectively, except that those at C19 and C20 were produced from a Sharpless AD reaction.
    通过高度收敛的合成策略实现了番荔枝苷(1)的首次全合成。除了C19和C20处的那些是由Sharpless AD反应产生的以外,所有的立体异构中心均分别来自三种天然羟基酸。
  • Structure, Sythesis and Absolute Configuration of Leptosphaerin, a Metabolite of the Marine Ascomycete Leptosphaeria oraemaris.
    作者:James D. White、Rodney A. Badger、Hollis S. Kezar、Alexander J. Pallenberg、Guy A. Schiehser
    DOI:10.1016/s0040-4020(01)89133-x
    日期:1989.1
    spectroscopic evidence and an ambiguous x-ray analysis was disproved by synthesis. An alternative formulation 1, including its absolute configuration, was confirmed by a stereospecific synthesis that began with condensation of the acetonide 8 of (R)-glyceraldehyde with the dianion from(Z)-N-methyl-2-benzyloxy-3-phenylthioacrylamide (34). The derived α-hydroxy lactone 43 was converted to the enamide moiety
    根据光谱证据错误推导了海洋真菌代谢产物瘦球菌素的结构3,并通过合成证明了模糊的X射线分析。立体定向合成证实了另一种制剂1的绝对构型,包括其绝对构型,该立体特异性合成始于(R)-甘油醛的丙酮化物8与(Z)-N-甲基-2-苄氧基-3-苯基硫代丙烯酰胺的二价阴离子的缩合反应(34)。衍生的α-羟基内酯43通过叠氮基内酯45的分解而被转化为瘦球蛋白的酰胺部分。。因此,脂球蛋白是(4S,5R)-2-乙酰氨基-4,5,6-三羟基-2-己烯酸的γ-内酯,因此是D氨基己糖的衍生物。
  • Stereoselective process for the preparation of 2-amino-ethanol
    申请人:Zambon Group S.p.A
    公开号:US05142066A1
    公开(公告)日:1992-08-25
    A stereoselective process for the preparation of the compounds of formula ##STR1## wherein R, R.sub.1, R.sub.2, a and b have the meanings reported in the specification, is described. The compounds of formula I have a remarkable central analgesic activity and they are useful in the pharmaceutical field.
    本发明提供了一种立体选择性的方法,用于制备公式##STR1##中R、R.sub.1、R.sub.2、a和b的化合物。其中R、R.sub.1、R.sub.2、a和b的含义在说明书中有所描述。公式I的化合物具有显著的中枢镇痛活性,并且在制药领域中有用。
  • Kalwinsh, Ivars; Metten, Karl-Heinz; Brueckner, Reinhardt, Heterocycles, 1995, vol. 40, # 2, p. 939 - 952
    作者:Kalwinsh, Ivars、Metten, Karl-Heinz、Brueckner, Reinhardt
    DOI:——
    日期:——
  • Unexpected Stereochemistry in the Lithium Salt Catalyzed Ring Expansion of Nonracemic Oxaspiropentanes. Formal Syntheses of (−)-(4<i>R</i>,5<i>R</i>)-Muricatacin and the Pheromone (<i>R</i>)-Japonilure
    作者:Angela M. Bernard、Angelo Frongia、Pier P. Piras、Francesco Secci
    DOI:10.1021/ol035061r
    日期:2003.8.1
    The stereochemistry of the cyclobutanones 3, obtained by lithium salt catalyzed ring expansion of the optically pure oxaspiropentanes 2, depends not only on the lithium salt but also on the stereochemistry of 2. They constitute the starting material for the syntheses of the acetogenin (-)-(4R,5R)-muricatacin and the pheromone (R)-japonllure.
查看更多